Default Category
-
Lehman Brothers
Nicholas, Tom; Chen, DavidCase HBS-810106-EEntrepreneurshipIn 2008, the U.S. financial system was in a state of crisis and Lehman Brothers went from a major Wall Street investment bank to an insolvent institution. It was a swift end for a firm that had its beginnings over 150 years prior. What would be the firm's legacy? And how, if at all, had its activities changed the course of American history?Starting at €8.20
-
U.S. Healthcare Reform: Reaction to the Patient Protection and Affordable Care Act of 2010
Daemmrich, Arthur A.Case HBS-711103-EEconomicsSupplement to "U.S. Healthcare Reform: International Perspectives," HBS No. 710-040, updating key events and disputes concerning the reform law, including the 2010 Congressional elections, legislative proposals, legal challenges, and responses by employers.Starting at €8.20
-
The American Dream in History
Nicholas, Tom; Chen, DavidCase HBS-808134-EEntrepreneurshipStarting at €8.20
-
The Indian Removal Act and the
Nicholas, Tom; Medoff, Ari; Smith, RavenCase HBS-812079-EEconomicsNative Americans were subjected to a protracted and painful process of forced removal from their land. The case provides "first hand" evidence on the debate over Indian removal as it took place during the early nineteenth century. The first document is excerpted from Andrew Jackson's First Annual Message to Congress in 1829 and the second document from Jackson's Second Annual Message in 1830, the year the Indian Removal Act was passed. The third ...Starting at €8.20
-
Kleiner-Perkins and Genentech: When Venture Capital Met Science
Hardymon, G. Felda; Nicholas, TomCase HBS-813102-EEntrepreneurshipGenentech is a rare success story in the biotechnology industry. Hundreds of billions of dollars of venture capital have been invested without the expected transformational effects. Established in 1976, Genentech was to develop the new science of recombinant DNA into viable therapeutic products with mass market appeal, something that most scientists agreed was at least a decade away. The founders, Herbert Boyer and Robert Swanson had limited fina...Starting at €8.20
-
Samuel Colt: An American Gun Maker
Nicholas, Tom; Verkamp, CaseyCase HBS-815061-EEntrepreneurshipSamuel Colt not only perfected and patented the technology for a gun that could fire multiple times without reloading, but he also developed and applied early principles of mass production more completely than anyone had done before. Until the nineteenth century, weapons manufacture, like most industries, had been the exclusive domain of skilled craftsmen, whose families had typically been in the trade for generations. Colt substituted specialize...Starting at €8.20
-
The Flint, Michigan Sit-Down Strike, Teaching Note
Stanton, Christopher; Nicholas, TomTeaching Note HBS-818107-ETeaching note for case 817005.Starting at €0.00
-
A Managerial Perspective on Clinical Trials
Daemmrich, Arthur A.Case HBS-709033-EEntrepreneurshipThis note describes the history and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70 percent of a drug's total development costs, pharmaceutical and biotechnology leaders need to understand clinical trial management. Likewise, with a growing variety of new product i...Starting at €8.20
-
Targanta Therapeutics: Hitting a Moving Target, Teaching Note
Daemmrich, Arthur A.Teaching Note HBS-710006-EEntrepreneurshipTeaching Note for [709002].Starting at €0.00
-
Arcadia Biosciences: Seeds of Change (Abridged)
Daemmrich, Arthur A.Case HBS-711050-EArcadia Biosciences is seeking to introduce genetically modified rice to China that will lower farmers' costs and generate environmental benefits through reduced greenhouse gas emissions. The case describes challenges facing this small agricultural biotechnology company, notably uneven enforcement of intellectual property in emerging market countries, and uncertainty regarding the provision and market value of carbon credits under international c...Starting at €8.20